Table 5.
PTSD | No-PTSD CG | Analysis | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Median | Mean | SD | CImean | Median | Mean | SD | CImean | p | d | CId | |
Drug therapies | |||||||||||
2 years pre | 56 | 390 | 4057 | 320–460 | 29 | 257 | 5898 | 207–308 | 0.02 | 0.00–0.04 | |
1 year pre | 65 | 441 | 4204 | 368–513 | 30 | 280 | 6301 | 226–334 | 0.03 | 0.01–0.05 | |
Index year | 70 | 521 | 4441 | 444–598 | 32 | 295 | 2929 | 269–320 | * | 0.07 | 0.05–0.09 |
1 year post | 72 | 584 | 5063 | 497–672 | 33 | 326 | 2275 | 306–346 | * | 0.09 | 0.07–0.10 |
2 years post | 72 | 629 | 5181 | 540–719 | 34 | 399 | 6025 | 347–451 | * | 0.04 | 0.02–0.06 |
Total | 405 | 2565 | 21,255 | 2198–2932 | 205 | 1557 | 20,843 | 1377–1737 | * | 0.05 | 0.03–0.07 |
Outpatient treatments | |||||||||||
2 years pre | 302 | 454 | 603 | 443–464 | 231 | 349 | 445 | 345–353 | * | 0.22 | 0.20–0.24 |
1 year pre | 332 | 493 | 604 | 482–503 | 246 | 370 | 482 | 366–374 | * | 0.24 | 0.22–0.26 |
Index year | 310 | 493 | 717 | 480–505 | 254 | 386 | 508 | 382–390 | * | 0.19 | 0.17–0.21 |
1 year post | 307 | 486 | 640 | 475–497 | 266 | 407 | 542 | 403–412 | * | 0.14 | 0.12–0.16 |
2 years post | 317 | 495 | 641 | 484–506 | 279 | 430 | 600 | 425–435 | * | 0.11 | 0.09–0.13 |
Total | 1876 | 2421 | 2107 | 2384–2457 | 1533 | 1942 | 1762 | 1927–1958 | * | 0.26 | 0.24–0.28 |
Inpatient treatments | |||||||||||
2 years pre | 0 | 637 | 2650 | 591–682 | 0 | 326 | 1682 | 312–341 | * | 0.16 | 0.14–0.18 |
1 year pre | 0 | 804 | 4530 | 726–882 | 0 | 357 | 2042 | 339–374 | * | 0.16 | 0.15–0.18 |
Index year | 0 | 648 | 3018 | 596–700 | 0 | 367 | 3076 | 341–394 | * | 0.09 | 0.07–0.11 |
1 year post | 0 | 560 | 2215 | 521–598 | 0 | 418 | 2192 | 399–437 | * | 0.06 | 0.05–0.08 |
2 years post | 0 | 579 | 2347 | 539–620 | 0 | 450 | 5009 | 406–493 | * | 0.03 | 0.01–0.05 |
Total | 295 | 3227 | 8156 | 3087–3368 | 0 | 1918 | 7910 | 1849–1986 | * | 0.17 | 0.15–0.18 |
Sickness benefit payments | |||||||||||
2 years pre | 0 | 121 | 1054 | 103–140 | 0 | 47 | 599 | 42–52 | * | 0.10 | 0.09–0.12 |
1 year pre | 0 | 162 | 1279 | 140–184 | 0 | 51 | 634 | 46–57 | * | 0.14 | 0.12–0.16 |
Index year | 0 | 205 | 1522 | 178–231 | 0 | 58 | 676 | 52–64 | * | 0.16 | 0.14–0.18 |
1 year post | 0 | 96 | 937 | 80–112 | 0 | 67 | 754 | 60–73 | 0.04 | 0.02–0.06 | |
2 years post | 0 | 89 | 915 | 73–104 | 0 | 78 | 848 | 71–85 | 0.01 | − 0.01 to 0.03 | |
Total | 0 | 672 | 3262 | 616–729 | 0 | 301 | 1995 | 284–319 | * | 0.16 | 0.14–0.18 |
Losses of gross value | |||||||||||
2 years pre | 0 | 1794 | 5742 | 1695–1893 | 0 | 971 | 3489 | 941–1001 | * | 0.20 | 0.18–0.22 |
1 year pre | 0 | 1993 | 6424 | 1882–2104 | 0 | 1043 | 3635 | 1011–1074 | * | 0.22 | 0.20–0.24 |
Index year | 0 | 1858 | 6636 | 1744–1973 | 0 | 1080 | 3691 | 1048–1111 | * | 0.18 | 0.16–0.20 |
1 year post | 0 | 1520 | 4814 | 1437–1603 | 0 | 1176 | 4008 | 1142–1211 | * | 0.08 | 0.06–0.10 |
2 years post | 0 | 1626 | 5115 | 1538–1714 | 0 | 1329 | 4506 | 1290–1368 | * | 0.06 | 0.05–0.08 |
Total | 0 | 8792 | 18,815 | 8467–9116 | 0 | 5599 | 12,841 | 5488–5709 | * | 0.22 | 0.21–0.24 |
Total costs | |||||||||||
2 years pre | 851 | 3396 | 8913 | 3243–3550 | 478 | 1951 | 7915 | 1883–2019 | * | 0.18 | 0.16–0.20 |
1 year pre | 954 | 3892 | 10,774 | 3706–4078 | 507 | 2101 | 8265 | 2030–2172 | * | 0.20 | 0.18–0.22 |
Index year | 849 | 3725 | 10,540 | 3543–3907 | 534 | 2186 | 6726 | 2127–2244 | * | 0.20 | 0.18–0.22 |
1 year post | 923 | 3245 | 8450 | 3100–3391 | 568 | 2394 | 6390 | 2339–2450 | * | 0.12 | 0.11–0.14 |
2 years post | 954 | 3419 | 8918 | 3265–3573 | 617 | 2685 | 12,067 | 2581–2790 | * | 0.06 | 0.04–0.08 |
Total | 7894 | 17,677 | 34,196 | 17,087–18,267 | 5024 | 11,317 | 31,521 | 11,045–11,590 | * | 0.20 | 0.18–0.22 |
Costs are expressed in euros (EUR)
CI 95% confidence intervals
*Significant test results for Student’s t test after Bonferroni-correction (p < 0.001/36 = 0.000027)